InvestorsHub Logo
Followers 23
Posts 2618
Boards Moderated 0
Alias Born 12/28/2014

Re: None

Saturday, 05/07/2016 1:16:08 AM

Saturday, May 07, 2016 1:16:08 AM

Post# of 55244
Juno is working in the cutting-edge field of cell therapy, in which patients’ own cells are re-engineered I wonder if this is like TCel in some way.
Who knows Maybe someone like this would buy out TCEL 1 or 2 cents a share would be good